Trials / Terminated
TerminatedNCT04232449
Oral Corticosteroids for Post-infectious Cough in Adults
Oral Corticosteroids for Post-infectious Cough in Adults: A Double-blind Randomised Placebo-controlled Trial in Swiss Family Practices (OSPIC Trial)
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- University Hospital, Basel, Switzerland · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess whether a 5-day treatment with orally administered prednisone provides patient-relevant benefits by improving the cough-related QoL of patients with post-infectious cough triggered by an Upper Respiratory Tract Infection (URTI) and seeking care in adult primary care practices. The study aims to describe an efficacy and safety profile for a 5-day prednisone treatment compared to a 5-day course of placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PREDNISON Galepharm Tabl. 20 mg | 5 daily- doses of 40 mg (2 tablets of 20 mg) of prednisone |
| DRUG | placebo tablets | 5 daily- doses of placebo (2 tablets) |
Timeline
- Start date
- 2020-11-06
- Primary completion
- 2024-04-30
- Completion
- 2024-04-30
- First posted
- 2020-01-18
- Last updated
- 2024-07-03
Locations
2 sites across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT04232449. Inclusion in this directory is not an endorsement.